We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Ex vivo radiosensitivity is increased in non-cancer patients taking valproate.
- Authors
Stritzelberger, Jenny; Lainer, Jennifer; Gollwitzer, Stefanie; Graf, Wolfgang; Jost, Tina; Lang, Johannes D.; Mueller, Tamara M.; Schwab, Stefan; Fietkau, Rainer; Hamer, Hajo M.; Distel, Luitpold
- Abstract
<bold>Background: </bold>Valproate (VPA) is a commonly prescribed antiepileptic drug for patients experiencing epileptic seizures due to brain tumors. VPA increases radiation sensitivity in various tumor cells in vitro due to complex mechanisms. This could make tumors more vulnerable to ionizing radiation or overcome radioresistance. Yet, clinical data on possible improvement of tumor control by adding VPA to tumor therapy is controversial. Potentially radiosensitizing effects of VPA on healthy tissue remain unclear. To determine individual radiosensitivity, we analyzed blood samples of individuals taking VPA.<bold>Methods: </bold>Ex vivo irradiated blood samples of 31 adult individuals with epilepsy were studied using 3-color fluorescence in situ hybridization. Aberrations in chromosomes 1, 2 and 4 were analyzed. Radiosensitivity was determined by the mean breaks per metaphase (B/M) and compared to age-matched (2:1) healthy donors.<bold>Results: </bold>The patient cohort (n = 31; female: 38.7%) showed an increase of their average B/M value compared to healthy individuals (n = 61; female: 56.9%; B/M: 0.480 ± 0.09 vs. 0.415 ± 0.07; p = .001). The portion of radiosensitive (B/M > 0.500) and distinctly radiosensitive individuals (B/M > 0.600) was increased in the VPA group (54.9% vs. 11.3 and 9.7% vs. 0.0%; p < .001). In 3/31 patients, radiosensitivity was determined prior to and after VPA treatment and radiosensitivity was increased by VPA-treatment.<bold>Conclusions: </bold>In our study, we confirmed that patients treated with VPA had an increased radiosensitivity compared to the control group. This could be considered in patients taking VPA prior to the beginning of radiotherapy to avoid toxic side effects of VPA-treatment.
- Subjects
FLUORESCENCE in situ hybridization; CHROMOSOME abnormalities; IONIZING radiation; EPILEPSY; PEOPLE with epilepsy
- Publication
BMC Neurology, 2020, Vol 20, Issue 1, pN.PAG
- ISSN
1471-2377
- Publication type
journal article
- DOI
10.1186/s12883-020-01966-z